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Background: Musk is widely used in clinical practice for its anti-cancer properties. Here, we treated various types
of cancer using musk to determine which cancers are sensitive to musk treatment. We also compared effects of
native musk and synthetic musk ketone in cancer cells. Furthermore, we investigated mechanisms underlying
effects of musk.
Methods: Twenty two cancer cell lines were treated with musk. Cell proliferation and apoptosis analyses were
carried out. Native musk and synthetic musk ketone were analyzed by gas chromatograph-mass spectrometer
(GC-MS) assay. Differentially expressed genes were determined by microarray and quantitative real–time polymerase
chain reaction.
Results: Native musk strongly induced the growth repression and the apoptosis in the majority of cancer cell lines
in a dose-dependent manner, but distinct types of cancer showed significantly different reactions. Cancer cells
which originated from epithelial cells showed higher sensitivity for musk treatment. By contrast, leukaemia and
lymphoma cells were not sensitive. GC-MS analysis demonstrated that native musk contains more than 30 contents
in which musk ketone is a major component; synthetic musk ketone was consistent with natural musk ketone, and
the used sample of synthetic musk ketone contained only sole component. Similar to native musk, synthetic musk
ketone induced the growth repression and the apoptosis of cancer cells. Additionally, numerous genes were
differentially expressed in lung cancer cells after native musk treatment. These differentially expressed genes were
involved in many signalling pathways. Among these pathways, apoptosis-related pathways included interleukin
family, tumor necrosis factor family, and MAPK signalling pathway. Native musk and synthetic musk ketone can
up-regulate IL-24 (interleukin family) and DDIT3 (MAPK signalling pathway) in lung cancer cells.
Conclusions: This research provided strong evidence that native musk and synthetic musk ketone can induce
the growth repression and the apoptosis of cancer cells. However, the selection of sensitive cancer patient for
individualized treatment is a key step in clinical application. Synthetic musk ketone can substitute for native musk
to treat cancer patients. Musk might induce the growth repression and the apoptosis of lung cancer cells through
up-regulating IL-24 and DDIT3 expressions.
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Cancer is one of the vital causes of death worldwide.
Anti-cancer drugs play important roles in cancer treat-
ment. Although increasing numbers of anti-cancer drugs
have been applied in clinical practice, most cancer pa-
tients presented poor prognosis because of lack of effect-
ive treatment. Therefore, novel anti-cancer drugs should
be developed. Traditional Chinese medicine (TCM) has
been used to treat gas heavy diseases (now regarded as
malignant tumors by modern medicine) for thousands of
year. From TCM, several effective anti-cancer drugs had
been discovered and developed, such as arsenic trioxide
(As2O3) for treatment of acute promyelocytic leukaemia
[1, 2] and camptothecin for solid tumours [3]. And some
new cancer treatments were studied [4, 5]. TCM pos-
sesses advantages in specific aspects at a certain stage of
cancer treatment [6]. Musk (Shexiang, Moschus), as a
common and valuable TCM, is widely applied to treat
various diseases. Clinically, musk is used for anti-
bacterial, anti-inflammatory, immunity-enhancing, and
treatments of gas heavy diseases in clinical practice. As
recorded in several ancient TCR books such as “Shen
Nong Ben Cao Jing (The Herbal Classic of the Divine
Plowman)” and “Compendium of Material Medicine”,
musk exerts a therapeutic effect for gas heavy diseases.
In the 1970s, musk had been studied for the treatment
of gastrointestinal cancer [7]. In the 1990s, a TCM
named ‘compound TIANXIAN capsule’ which contained
musk as the main ingredient, was used to treat gastro-
intestinal tumors and had shown a certain effect [8]. In a
previous study, musk was buried within the abdomen
after radical gastrectomy for stomach cancer, and this
treatment significantly prolonged the survival time of
patients [9]. Recently, several reports demonstrated
that Xihuang pill which contains musk, revealed anti-
breast cancer effects [10]. Moreover, Toona sinensis
and Moschus decoction induced cell cycle arrest in
HeLa cells [11].
Although musk treatment was effective for tumor pa-
tients, some cancer patients did not respond to musk
treatment in clinical applications. Thus, cancer sensitiv-
ity should be determined in order to enhance the effect-
iveness of musk therapy. In the present study, we treated
various cancer cell lines with musk to determine which
cancers were sensitive to musk treatment. The results
may be helpful to select appropriate treatments for pa-
tients and to guide clinical therapy.
Native musk is obtained from the capsule gland of
male musk deer and its source is very limited. Thus, the
use of synthetic compound instead of native musk
provides a great significance for clinical application.
Native musk primarily contains musk ketone, nitrogen-
containing compounds, cholesterol, fatty acids, and
inorganic salts. These materials have anti-bacterial, anti-inflammatory, immunity-enhancing, and anti-tumor ef-
fects [12]. Musk ketone, a major component of native
musk, had been used for cancer treatment. A previous
study found that synthetic musk ketone could signifi-
cantly inhibit the growth of breast cancer cells in a nude
mouse model [13]. In the current study, we compared
responses of cancer cells to native musk and synthetic
musk ketone in vitro.
Although musk treatment suppressed the tumor
growth in clinical application, and experimental studies
confirmed that musk could inhibit cancer cell prolifera-
tion and trigger apoptosis [7–9, 14]. However, mecha-
nisms underlying these effects remain unknown. In this
study, we also investigated signalling pathways associ-
ated with the growth inhibition and the apoptosis in
lung cancer cells treated by musk.Methods
Native musk and synthetic musk ketone
The native musk sample was obtained from the gland
capsule of a dead musk deer. This musk deer died of
natural causes. The dead musk deer was provided by Li-
Jiang City, Yunnan Province, China. The musk deer be-
longs to Moschus berezovskii. The study was approved
by the Ethics Committee for Animal Experimentation,
Kunming Institute of Zoology, Chinese Academy of Sci-
ences. The native musk sample (0.076 g) was added to
1 ml of ethanol and the mixture was shaken for 1 hour
(h). The supernatant was filtered through a 0.22 μm
filter and stored at 4 °C. Gas chromatograph-mass
spectrometer-computer (GC-MS) analysis confirmed
that main ingredients of native musk were extracted.
The sample of synthetic musk ketone (the purity: 98%)
was purchased from Chengdu Preferred Biotechnology.
Co. Ltd (CAS: 541-91-3, Lot No.13709; Chengdu,
China), and this sample was dissolved in ethanol, filtered
through a 0.22 mm filter and stored at 4 °C. The chem-
ical structure of synthetic musk ketone was showed in
Additional file 1.Cell lines and cell culture
Up to 22 human cancer cell lines were used in this
study. These cell lines included 11 types of cancer such
as lung squamous cell carcinoma, lung adenocarcinoma,
lung large cell carcinoma, lung small cell carcinoma,
mammary carcinoma, esophageal carcinoma, gastric car-
cinoma, colorectal carcinoma, hepatocellular carcinoma,
acute myelogenous leukemia, and B cell lymphoma.
These cell lines were cultured with RPMI 1640 or
DMEM medium (GIBCO Invitrogen, Grand Island, NY,
USA) containing 10% foetal bovine serum and main-
tained in a humidified incubator with 5% CO2 at 37 °C.
XLA-07 and XL-JT were provided by Dr LJ Ma [15].
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Additional file 2.Cell proliferation assay
Cultured cells were seeded in 96-well plates at a density
of 1 × 104 cells per well. Native musk and synthetic musk
ketone (four replicates in each group) were added at
varying concentrations. After 24 h of treatment, 20 μl of
MTS solution [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner
salt; Promega Corporation, Madison, WI, USA] was added
to each well, and the plates were incubated for 4 h at
37 °C. Absorbance at 490 nm was measured using a
spectrophotometer. The same amount of solvent
(ethanol) was used as the control.Flow cytometry (FCM) analysis
Apoptotic cells were determined by FCM analysis with
the Fluorescein Isothiocyanate (FITC)-labeled Annexin
V Kit (BD Pharmingen, San Diego, CA, USA) in accord-
ance with the manufacture’ instruction. Treated cells
were washed twice with phosphate buffer saline (PBS)
and adjusted at a density of 5 × 105 cells/100 μl. Cell
suspensions were added to each tube; afterward, the
cells were stained with annexin V-FITC and propi-
dium iodide and then analyzed under FCM (BD Bio-
sciences, San Jose, CA, USA). Collected data for
10,000 cells and WinMDL software were used for the
analysis of FCM data files.GC-MS analysis
The native musk sample was extracted with ethanol as
described above. The supernatant was filtered and deter-
mined by GC-MS (Agilent Technologies, Palo Alto, CA,
USA; HP6890GC/5973MS) as previous described [16].
Similarly, 1 μl of the musk ketone sample was dissolved
in 100 μl of ethanol and then determined by GC-MS.
Qualitative analysis was performed with the Wiley7n.l
standard library.mRNA expression profiling
Harvested cells were washed twice with cold PBS, and
total RNA was isolated using Trizol reagent (TaKaRa,
Tokyo, Japan). Determination of mRNA profiling was
performed in Eplc-32M1 and XL-JT cells with or with-
out native musk treatment by using Agilent Human
Gene Expression array (CapitalBio Technology, Beijing,
China; http://www.capitalbio.com). Differentially expressed
genes were subjected to Gene Ontology (GO) as well as
Kyoto Encyclopedia of Genes and Genomes (KEGG) path-
way analyses using Molecule Annotation System (MAS) 3.0
(http://bioinfo.capitalbio.com/mas3).Quantitative real–time polymerase chain reaction (qRT-PCR)
For mRNA expression assay, total RNA was isolated
from cells by using TRlzol reagent (TaKaRa). Synthesis
of cDNA was carried out by M-MLV Reverse Transcript-
ase (Promega) with random primer and amplified with
specific primers on the StepOne Realtime PCR System
(Applied Biosystems, Foster City, CA, USA). QRT-PCR
analysis was performed using miScript SYBR Green PCR
kit (QIAGEN, Hilden, Germany) in accordance with the
manufacturer’s instructions. The PCR reaction process
was first incubated at 95 °C for 3 minutes (min),
followed by 40 cycles of thermal cycling at 95 °C for
15 seconds (s) and 60 °C for 30 s. The mRNA levels of
the target genes were demonstrated using ΔCT (ΔCT =
CT, Target-CT, actin; CT, Target, the average threshold cycle
number of the target gene; CT, actin, the average thresh-
old cycle number of the β-actin). The primer sequences







Statistical significance was calculated using the Student’s
t-test. SPSS 17.0 software package (Chicago, IL, USA)
was used for all statistical analyses. The level of statis-
tical significance was set at 0.05 for all the tests.
Results
Native musk treatment inhibited the proliferation of
cancer cells and induced the apoptosis
Up to the 22 cancer cell lines were used in this study.
Cultured cells were exposed to various concentrations
(0.025, 0.05, 0.1, 0.2, 0.4, and 0.8 mg/ml) of native musk
for 24 h. The data indicated that musk treatment in-
duced the growth repression in the 17 cancer cell lines
in a dose-dependent manner, but did not show any effect
in the 5 other cancer cell lines. The results are summa-
rized in Table 1. In particular, native musk strongly
inhibited the growth of the three lung cancer cell lines;
likewise, the growth of several carcinoma cell lines were
strongly suppressed (Fig. 1a to f). Moreover, native musk
selectively targeted the 12 cancer cell lines and pro-
moted the apoptosis of cancer cells (Fig. 1g to l).
Synthetic musk ketone inhibited the proliferation of
cancer cells and induced the apoptosis
In this study, we selected the six cancer cell lines which
showed positive response for native musk to analyze
effects of synthetic musk ketone. Cultured cells were ex-
posed to various concentrations (0.025, 0.05, 0.1, 0.25,
and 0.5 mg/ml) of synthetic musk ketone for 24 h. MTS
Table 1 Reactivities of various cancer cell lines after treatment
with native musk
Cell lines Reactivitiesa







Lung large cell carcinoma
NCIH-460 -
801-D -























aReactivities mean inhibition rates of the cellular proliferation after the treatment
The inhibition rates: −, <10%; +, 10–20%; ++, 20–40%; +++, 40–60%; ++++, 60–80%
The concentration of native musk: 0.8 mg/ml
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synthetic musk ketone in the selected cancer cell lines.
These results indicated that synthetic musk ketone can
also induce the growth repression and the apoptosis in
the six cancer cell lines in a dose-dependent manner
(Table 2, Fig. 2). Notably, synthetic musk ketone exerted
significant effects under low concentration compared
with native musk.Native musk and synthetic musk ketone were analyzed
and compared by GC-MS assay
Results of GC-MS assay demonstrated that native musk
contains more than 30 contents. Up to the 12 notable
peaks were selected for further analysis (Fig. 3a). The 12
contents are presented in Fig. 3b. Among the 12 contents,
the amount of musk ketone was the highest, reaching
27.12%. Moreover, GC-MS assay revealed that the sample
of synthetic musk ketone used in this study contains only
one component that is musk ketone (Fig. 3c).
mRNA expression scan identified differentially expressed
genes after native musk treatment
To explore molecular mechanisms associated with musk
treatment of lung cancer, we performed microarray ana-
lysis to determine mRNA profiles of Eplc-32M1 and XL-
JT following native musk treatment. Differentially
expressed genes in Eplc-32M1 and XL-JT after the treat-
ment are listed in Additional files 3 and 4, respectively.
These differentially expressed genes were grouped into
approximate 30 categories. These results indicated that
musk has a wide range of biological activities. In this
study, we were particularly interested in apoptosis-
related signalling pathways because of their potential
roles in the growth repression and the apoptosis induced
by musk.
Possible pathways were involved in the apoptosis
induced by native musk and synthetic musk ketone
Analyses of differentially expressed genes showed that
signalling pathways related with the musk induced-
apoptosis included interleukin (IL) family, tumor necro-
sis factor (TNF) family, MAPK signalling pathway, p53
signalling pathway, and Jak-STAT signalling pathway.
The three common genes (IL-24, interleukin family;
TNFRSF25, TNF family; DNA-damage-inducible tran-
script 3 [DDIT3], MAPK signalling pathway) that were
differentially expressed in both Eplc-32M1 and XL-JT
cells treated with native musk, were selected for further
analysis. The mRNA levels of the three genes were veri-
fied in Eplc-32M1 and XL-JT cells treated with native
musk and synthetic musk ketone via qRT-PCR analyses.
The treatment of native musk induced up-regulation of
the three genes (IL-24, TNFRSF25, and DDIT3), whereas
the treatment of synthetic musk ketone led to up-
regulation of the two genes (IL-24 and DDIT3; Fig. 4).
Discussion
Experiences in TCM for thousand years and researches
on modern medicine have demonstrated that musk
treatment is effective for tumor therapy [7–9, 14]. How-
ever, the therapeutic effect of musk showed significant
differences in various cancer patients. The principle of
‘personalized therapy’ or ‘precision medicine’ indicated
Fig. 1 Native musk induced the growth repression and the apoptosis in cancer cell lines. a-f Native musk inhibited the cellular proliferation in the
six carcinoma cell lines, as shown by MTS assay. g–l Native musk induced the apoptosis in the six carcinoma cell lines, as shown by FCM assay.
Student’s t-test, p < 0.05
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ized treatment, particularly for cancer therapy, is of great
significance. Distinct types of cancer may show different
responses to the same treatment. In the present study,
we applied various types of cultured cancer cells to in-
vestigate their response to musk treatment. The cancer
cells examined in this study belong to lung cancer,
esophagus cancer, stomach cancer, colon cancer, liver
cancer, breast cancer, leukaemia, and lymphoma. Our re-
sults demonstrated that: 1) musk can induce the growth
repression and the apoptosis of cancer cells, which pro-
vided a clear scientific basis for cancer therapy using
musk; 2) the therapeutic effect of musk was dose-
dependent. 3) importantly, various cancers showed
significantly different responses to musk treatment. Forinstance, cancer cells which originated from epithelial
cells were highly sensitive for musk treatment. By con-
trast, leukaemia and lymphoma cells were not sensitive.
We also emphasized that even for the same type of car-
cinoma, distinct cell lines displayed significant difference
in terms of sensitivity. Thus, we proposed that sensitive
patients should be selected for individualized treatment
using musk through experimental methods and thera-
peutic trials.
In this study, we also found that the musk action was
dose-dependent, indicating that administration of high
doses may enhance the therapeutic effect. However,
musk produces certain toxic effects, and administration
of high doses may also be harmful to patients. Therefore,
the appropriate dose and the method of administration
Table 2 Reactivities of various cancer cell lines after treatment
with synthetic musk ketone
Cell lines Reactivitiesa











aReactivities mean inhibition rates of the cellular proliferation after the treatment
The inhibition rates: +, 10–20%; ++, 20–40%; +++, 40–60%; ++++, 60–80%
The concentration of synthetic musk ketone: 0.5 mg/ml
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China, TCM physicians treated severe infections and tu-
mors in lung as well as upper gastrointestinal tract
through inhalation and swallowing of small amounts of
native musk, respectively (personal communication).Fig. 2 Synthetic musk ketone induced the growth repression and the apop
proliferation in Eplc-32M1 (a; lung squamous cell carcinoma) and XLA-07 (d
significant effect at low concentration. Synthetic musk ketone induced the
assay. b and e were negative controls. Student’s t-test, p < 0.05This particular mode of administration achieved better
treatment effects compared with traditional methods,
such as oral and subcutaneous embedding of pills con-
taining native musk or synthetic musk ketone. We sug-
gested that musk may be applied in different ways for
treatments of various cancers as follows: swallowing and
oral administration for esophagus and stomach cancer,
external application for breast cancer, and inhalation for
lung cancer.
Native musk is a very rare and precious natural drug.
Studying and synthesizing its active ingredients is very
important in pharmacology and clinical medicine. Native
musk contains more than 30 contents. Among them,
musk ketone is a major component, accounting for 27%.
Previous research showed that synthetic musk ketone
exerted anti-tumor activity [13]. In the current study, we
used synthetic musk ketone to treat cultured cancer
cells. We found that synthetic musk ketone can also in-
duce the growth repression and the apoptosis of cancer
cells, similar to the effect of native musk. Furthermore,
GC-MS analysis demonstrated that synthetic musk
ketone used in our study was consistent with natural
musk ketone contained in native musk. The used sample
of synthetic musk ketone only included the soletosis in cancer cell lines. Synthetic musk ketone inhibited the cell
; lung adenocarcinoma). Notably, synthetic musk ketone exerted
apoptosis in Eplc-32M1 (b, c) and XLA-07 (e, f), as shown by FCM
Fig. 3 Native musk and synthetic musk ketone were analyzed and compared by GC-MS assay. a Native musk contains more than 30 contents, in
which the 12 notable peaks are detected. b The 12 notable peaks are explained; c the sample of synthetic musk ketone used in this study is a
single component
Xu and Cao BMC Complementary and Alternative Medicine  (2016) 16:511 Page 7 of 10component. Our study indicated that synthetic musk ke-
tone can substitute for native musk to treat cancer pa-
tients, and synthetic musk ketone may be a promising
anti-cancer drug. We also noted that native musk con-
tains multiple components. We thought that muskketone may be synergistic with other components to
play an anti-cancer effect during the native musk treat-
ment. However, relevant researches are lacking so far.
Musk possesses a wide range of biological activities
and pharmacological effects as well as has been used for
Fig. 4 IL-24, TNFRSF25, and DDIT3 were differentially expressed in cultured cancer cells after native musk and synthetic musk ketone treatments.
a Changes in IL-24, TNFRSF25, and DDIT3 mRNA were determined by microarray analysis in Eplc-32M1 and XL-JT after native musk treatment.
b–d IL-24, TNFRSF25 and DDIT3 mRNA levels were determined by qRT-PCR in Eplc-32M1, XL-JT, HSC, and TE-1 after native musk and synthetic
musk ketone treatments; musk, native musk; musk ketone, synthetic musk ketone; control, no treatment. Student’s t-test. **, p < 0.01; *, p < 0.05
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and anti-cancer treatments [17, 18]. In our study, both
native musk and synthetic musk ketone can inhibit the
growth of cancer cells and induce the apoptosis. How-
ever, mechanisms underlying the anti-cancer effect of
musk remain incompletely understood. Lung cancer is
the leading cause of cancer-related death in the word,
and the lung cancer treatment is a large problem, for ex-
ample, the overall 5-year survival rate of lung cancer hasmerely improved from 12 to 16% over the recent 3 de-
cades. Here, we focused on mechanisms of the growth
repression and the apoptosis induced by musk in lung
cancer cells. Microarray analysis showed that numerous
genes were differentially expressed in Eplc-32M1 and
XL-JT after native musk treatment. These differentially
expressed genes were involved in many signalling path-
ways. The pathways which may be responsible for the
growth repression and the apoptosis induced by native
Xu and Cao BMC Complementary and Alternative Medicine  (2016) 16:511 Page 9 of 10musk in lung cancer included interleukin family, TNF
family, MAPK signalling pathway, p53 signalling path-
way, and Jak-STAT signalling pathway.
Furthermore, microarray data were verified for the
three genes (IL-24, interleukin family; TNFRSF25, TNF
family; DDIT3, MAPK signalling pathway) by qRT-PCR
in Eplc-32M1 and XL-JT treated with native musk and
synthetic musk ketone. Notably, both native musk and
synthetic musk ketone can induce IL-24 and DDIT3 up-
regulation. IL-24, also named melanoma differentiation-
associated gene-7 (mda-7) and MDA-7/IL-24, is a
member of interleukin-10 family [19]. MDA-7/IL-24 acts
as a growth suppressor in melanoma and other cancer
cells [20]. Several studies revealed that MDA-7/IL-24
plays a key role in tumor inhibition [21–25]. TNFRSF25
(previously labelled death receptor 3) is a member of
TNF family. TNFRSF25 mediates the TNFSF15- and
TNFα-induced apoptosis of endothelial cells [26], and
participates in the apoptosis of human osteoblasts [27].
DDIT3 belongs to MAPK signalling pathway. DDIT3 co-
operates with KAT2A to up-regulate TNFRSF10A and
TNFRSF10B expressions and to induce the endoplasmic
reticulum stress-mediated apoptosis in lung cancer [28].
On the basis of these data and our observations, we
hypothesized that musk may induce the growth repres-
sion and the apoptosis of lung cancer cell through up-
regulating IL-24 and DDIT3 expressions. Musk reveals
multiple biological activities. Apart from inducing the
growth repression and the apoptosis of cancer cells,
musk also affects immune functions. Cytokines such as
interleukin and TNF, are important regulators of immune
functions. We assumed that cytokine alterations caused
by musk may be associated with mechanisms underlying
its anti-inflammatory and immunity-enhancing effects.
Mechanisms of musk action are very complex. Our re-
search is only a pilot study, and further works are
necessary.Conclusions
Overall, our research provided strong evidence that
native musk and synthetic musk ketone can induce
the growth repression and the apoptosis of cancer
cells in a dose-dependent manner. However, various
cancers showed significantly different responses to
musk treatment. Thus, the selection of sensitive can-
cer patient for individualized treatment is a key step
in clinical application. Synthetic musk ketone can
substitute for native musk to treat cancer patients.
Musk is expected to become one of adjuvant therap-
ies for anti-cancer treatment. Additionally, musk
might induce the growth repression and the apoptosis
of lung cancer cells through up-regulating IL-24 and
DDIT3 expressions.Additional files
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